TrialInternational journal of chronic obstructive pulmonary disease2013

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.

Teddy Kosoglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.